Editing Category talk:Utilities
Warning: You are not logged in.
Your IP address will be recorded in this page's edit history.The edit can be undone.
Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 1: | Line 1: | ||
− | + | Until August <a href=" http://birgitengelhardt.de/impressum/ ">misoprostol 200 mg ih</a> Cellectis specialises in genome engineering and stem cell treatment. Since its foundation in 1999, Dr Choulika says the company has developed new classes of products in biopharmaceutical production, agrobiotechnology, induced stem cells and alternative fuels. The group is due to launch a trial later this year with University College London on potential genetic therapies for chronic leukaemia. |